Table 2.

Proportion of subjects with serum progesterone concentration ≥10 ng/ml on day 5 of treatment‐FAS

FE 999913 (BID/TID) a				MEGASET trial progesterone preparation b				Difference c
N d	N e	Estimate (%)	95 % CI f	N d	N e	Estimate (%)	95 % CI f	Estimate (%)	95 % CI g
94	93	98.9	94.2; 100.0	632	631	99.8	99.1; 100.0	−0.9	−3.6;1.8

FAS full analysis set, BID bis in die/twice daily, TID ter in die/three times daily

^aData from the BID group and TID group were pooled

^bHistorical control

^cDifference = the current trial − the MEGASET trial

^dTotal number of subjects

^eNumber of subjects with serum progesterone concentration ≥10 ng/ml on day 5 of treatment

^f95 % CI was calculated based on the exact Clopper–Pearson method

^g95 % CI was calculated based on asymptotic normal distribution with a continuity correction